M Schlein1, S Ludvigsen, H B Olsen
1Health Care Discovery, Novo Nordisk A/S, Novo Alle 1, DK-2880 Bagsvaerd, Denmark. mosc@novonordisk.com
Researchers identified thymolphthalein as a potential oral diabetes treatment. This small molecule mimics insulin's effect on the insulin receptor (IR), offering partial insulin activity without injections.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: